A comprehensive view of hospital/clinical drugs. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Health Care Sector Market Intelligence Service.

Recent Articles

sample of recent headlines, press releases and get more..

Merck signs licensing deal for Sichuan Kelun Pharmaceutical’s oncology program for areas outside of China, Hong Kong, Macao, Taiwan; deal worth US$1.4B and may relate to experimental drugs SKB264 or A166 currently in Phase 2 testing in China

Arrowhead Pharmaceuticals swings to Q1 net income of US$44.4M from net loss of US$26.8M a year ago, with revenue up at US$151.8M from US$32.8M a year ago; firm lately initiated four studies, filed clinical trial applications for two investigational drugs

GlaxoSmithKline changes name to GSK as company spins-off consumer business, which will be known as Haleon

Novartis reports combination of Kisqali ribociclib and fulvestrant offer survival benefit of almost 16 months in previously untreated breast cancer versus fulvestrant alone; Kisqali is approved in more than 95 countries to treat breast cancer

FDA approves Eli Lilly’s oral Olumiant as a standalone COVID-19 treatment for hospitalized adult patients using supplemental oxygen or ventilation; Olumiant has treated over one million patients with sales up from US$437.0M in 2019 to US$1.1B in 2021

Ask us about our Health Care Sector market view

Trending Chart

Interactive chart with headline count